EFFECT OF ORMELOXIFENE IN WOMEN WITH ABNORMAL UTERINE BLEEDING AN INTERVENTIONAL STUDY
Not Applicable
- Conditions
- Health Condition 1: 1- ObstetricsHealth Condition 2: 1- Obstetrics
- Registration Number
- CTRI/2021/10/037387
- Lead Sponsor
- SHRI BM PATIL MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.BLEEDING MORE THAN 8 DAYS WITH HEAVY MENSTRUAL BLEEDING
2.PATIENT DIAGNOSED WITH AUB
Exclusion Criteria
1.PELVIC PATHOLOGIES LIKE SUSPECTED ADENOMYOSIS , UTERINE FIBROIDS , MALIGNANCIES OF UTERUS / CERVIX/ OVARY/VAGINA/ENDOMETRIAL HYPERPLASIA WITH ATYPIA
2.MEDICAL DISEASES LIKE - LIVER DYSFUNCTION , HEART DISEASE , MIGRAINE, STROKE , RENAL DISEASES , PLATELET DISORDERS OR COAGULOPATHY , PREVIOUS HISTORY OF THROMBOSIS , PREGNANCY , ABORTION , USE OF IUCD OR ORAL CONTRACEPTIVES , LACTATION WOMEN IN FURST 6 MONTHS OF POST NATAL PERIOD , HYPERSENSITIVITY OT THE DRUG
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method by measuring the menstrual blood lossTimepoint: at 12 weeks and 24 weeks
- Secondary Outcome Measures
Name Time Method acceptability and side effects of ormeloxifeneTimepoint: 3rd and 6th month